Publication | Closed Access

Meropenem (1.5 g/day) is as effective as imipenem/cilastatin (2 g/day) for the treatment of moderately severe intra-abdominal infections

AntibioticsMedicineSepsisPharmacotherapySevere Intra-abdominal InfectionsPharmacology